It is possible that, in the context of RA, L-carnitine may impact TGF-β1 levels indirectly or require longer treatment durations to manifest a measurable effect, given the complex regulatory networks involving TGF-β1 in fibrosis and immune responses. This evidence concerns the gene TGFB1 and rheumatoid arthritis.